TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26822105

Group type: EXPERIMENTAL
Intervention: Toothpaste with 1500 ppm fluoride
Number of subjects: 51

Group type: COMPARATOR
Intervention: Toothpaste with 0 ppm fluoride
Number of subjects: 51
Study: 25465736

Group type: EXPERIMENTAL
Intervention: Spinosad/MO
Number of subjects: 229

Group type: COMPARATOR
Intervention: CVP (Stronghold)
Number of subjects: 229

Group type: COMPARATOR
Intervention: CVP (Milbemax)
Number of subjects: 229
Study: 23647811

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (without n-3 PUFAs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs infusion and Control
Number of subjects: 20
Study: 21354370

Group type: EXPERIMENTAL
Intervention: 1-year trastuzumab
Number of subjects: 3398

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 3398

Group type: EXPERIMENTAL
Intervention: Selective-crossover cohort (non-randomised)
Number of subjects: 3398
Study: 19406658

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.2 microg/kg/min)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Dopexamine (2.0 microg/kg/min)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 42
Study: 17680910

Group type: EXPERIMENTAL
Intervention: Grazax (75,000 SQ‐T)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 14766335

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 to 80 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 to 40 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Statins (general)
Number of subjects: 11
Study: 11255134

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of Resistance Training and Walking (RT/W)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 19
Study: 9531360

Group type: EXPERIMENTAL
Intervention: Prophylactic radiation to the pelvic lymph nodes and prostatic bed (45 Gy in 4.5-5 weeks, plus 65 Gy in 6.5-8 weeks to the prostatic bed)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Prostatic bed alone (65 Gy in 6.5-8 weeks)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Staging laparotomy (SL)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Lymphangiogram (LAG)
Number of subjects: 449
Study: 8025759

Group type: EXPERIMENTAL
Intervention: ONO-1078 (225 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 6
Study: 2527051

Group type: EXPERIMENTAL
Intervention: Acitretin (0.34-0.44 mg/kg body weight) + UVB phototherapy (ReUVB)
Number of subjects: 41

Group type: COMPARATOR
Intervention: UVB phototherapy alone
Number of subjects: 41

Group type: COMPARATOR
Intervention: Acitretin alone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ReUVB
Number of subjects: 41
Study: 979832

Group type: EXPERIMENTAL
Intervention: Delta9-tetrahydrocannabinol (THC) 10 mg/70 kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol 0-5 g/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of THC and ethanol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ethanol alone
Number of subjects: 12
Study: 31593877

Group type: EXPERIMENTAL
Intervention: Intervention group (62 farms)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (11 farms)
Number of subjects: 100
Study: 28222225

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (DL-PDT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional photodynamic therapy (C-PDT)
Number of subjects: 26
Study: 25296725

Group type: EXPERIMENTAL
Intervention: LY2603618 (275 mg i.v. infusion) with desipramine (50 mg oral)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desipramine (50 mg oral) alone
Number of subjects: 30
Study: 23688282

Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 25
Study: 21693627

Group type: EXPERIMENTAL
Intervention: 1 cm-square with high prediagnostic mammographic density (MD)
Number of subjects: 231

Group type: COMPARATOR
Intervention: 1 cm-square in the lowest quartile of prediagnostic MD
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: 3 cm-square grid with high prediagnostic MD
Number of subjects: 231
Study: 19194313

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir film-coated tablet formulation (LPV/r-fct)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir soft gelatine capsules (LPV/r-sgc)
Number of subjects: 70
Study: 17544264

Group type: EXPERIMENTAL
Intervention: Formoterol 4.5 microg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Formoterol 18 microg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Formoterol 36 microg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15386822

Group type: EXPERIMENTAL
Intervention: Oralin spray (100 u)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Subcutaneous injection (0.1 u/kg)
Number of subjects: 23
Study: 11293553

Group type: EXPERIMENTAL
Intervention: Cefprozil (30 mg/kg/d in 2 divided doses)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (45/6.4 mg/kg/d plus amoxicillin 45 mg/kg/d in 2 divided doses)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 304

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 304
Study: 9555662

Group type: COMPARATOR
Intervention: G-699->C polymorphism in the putative promoter region
Number of subjects: 0

Group type: COMPARATOR
Intervention: A1098->G polymorphism in exon 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: B2R polymorphism (C181->T)
Number of subjects: 0
Study: 8035028

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF), 5 micrograms/kg daily for 10 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2646087

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg twice daily
Number of subjects: 144

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 144
Study: 1106311

Group type: EXPERIMENTAL
Intervention: Intermittent Positive Pressure Ventilation (IPPV)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Intermittent Positive-Negative Pressure Ventilation (IPNPV)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: IPPV
Number of subjects: 209

Group type: COMPARATOR
Intervention: IPNPV
Number of subjects: 209
Study: 31772347

Group type: EXPERIMENTAL
Intervention: HD-tDCS over the premotor cortex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HD-tDCS over the motor hotspot
Number of subjects: 0
Study: 30372675

Group type: EXPERIMENTAL
Intervention: GHRH treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 26239632

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) therapeutic dose (40 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) supratherapeutic dose (160 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MOXI; 400 mg)
Number of subjects: 56
Study: 24041330

Group type: EXPERIMENTAL
Intervention: Cochlear implant users (CI)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CI-simulation condition
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal hearing (NH) adults
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Degraded-speech groups (CI users and CI-simulation)
Number of subjects: 90
Study: 22291971

Group type: EXPERIMENTAL
Intervention: One-month learning rate
Number of subjects: 0
Study: 19827656

Group type: EXPERIMENTAL
Intervention: Anti-platelet treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcutaneous coronary interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists
Number of subjects: 0
Study: 17471136

Group type: EXPERIMENTAL
Intervention: Skin cooling using a cold-air system (SmartCool; Cynosure, Westford, MA)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ice cubes
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cold air blower
Number of subjects: 31
Study: 16160603

Group type: EXPERIMENTAL
Intervention: Folic acid, 10 mg/d for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11872674

Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (IV PROP, 80 microg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intra-arterial propranolol (IA PROP, 25 microg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous phentolamine (IV PHEN, 500 microg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intra-arterial phentolamine (IA PHEN, 12 microg/min per 100 ml forearm tissue)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (SAL)
Number of subjects: 12
Study: 9539464

Group type: EXPERIMENTAL
Intervention: Silica coating/Microfill Pontic C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etching/Clearfil F2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sandblasting/Panavia EX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified preparation form
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional preparation form
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maxillary restorations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mandibular restorations
Number of subjects: 0
Study: 7623532

Group type: EXPERIMENTAL
Intervention: Electronic messages designed to enhance adherence to clinical practice guidelines
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control group (no electronic messages)
Number of subjects: 349
Study: 2717366

Group type: EXPERIMENTAL
Intervention: Experimental alcohol intoxication (blood alcohol concentration of at least 0.10%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonalcohol placebo
Number of subjects: 0
Study: 1098132

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of glucose and insulin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Glucose infusions without insulin
Number of subjects: 15
Study: 30334908

Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 147

Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Waiting list patients
Number of subjects: 147
Study: 27714435

Group type: EXPERIMENTAL
Intervention: Transobturator (TO) sling (Monarc™)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Single incision (SI) sling (MiniArc™)
Number of subjects: 98
Study: 25416754

Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 6867
Study: 23077119

Group type: EXPERIMENTAL
Intervention: Life Goals Collaborative Care (LGCC, N = 29)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (N = 31)
Number of subjects: 60
Study: 21144505

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18083781

Group type: EXPERIMENTAL
Intervention: COX2 inhibition using 200 mg celecoxib once daily for 14 days
Number of subjects: 21
Study: 17211118

Group type: EXPERIMENTAL
Intervention: E-Mail educational program
Number of subjects: 99
Study: 12930861

Group type: EXPERIMENTAL
Intervention: Cold calling follow-up method
Number of subjects: 210

Group type: COMPARATOR
Intervention: Letters inviting appointment
Number of subjects: 210
Study: 11197785

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (NTG‐TTS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 27
Study: 9148337

Group type: EXPERIMENTAL
Intervention: Benznidazole (5 mg/kg/day for 30 days)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Nifurtimox (5 mg/kg/day for 30 days)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 8241095

Group type: EXPERIMENTAL
Intervention: pravastatin 40 mg/d
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: fish oil 6 g/d (equivalent to 3 g omega-3 fatty acids/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: combined therapy of pravastatin 40 mg/d plus fish oil 6 g/d
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 2862810

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 0
Study: 31881614

Group type: EXPERIMENTAL
Intervention: 1,4-Diaminobutane (1,4 DAB) 0.8% cream applied once per day at night
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 1,4-Diaminobutane (1,4 DAB) 0.8% cream
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham treatment (cream base alone)
Number of subjects: 44
Study: 30373571

Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine pretreatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: 2% chlorhexidine pretreatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 26630547

Group type: EXPERIMENTAL
Intervention: Balance training (BAL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pilates training (PIL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 48
Study: 26541842

Group type: EXPERIMENTAL
Intervention: sitagliptin plus insulin
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo plus insulin
Number of subjects: 30
Study: 24309198

Group type: EXPERIMENTAL
Intervention: Probiotic (lactobacilli and bifidobacteria, 6 x 10^10 organisms per day for 21 days)
Number of subjects: 2981

Group type: COMPARATOR
Intervention: Placebo (inert maltodextrin powder)
Number of subjects: 2981

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 2981

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2981
Study: 20510987

Group type: EXPERIMENTAL
Intervention: Motor imagery integrated into usual therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual therapy only (Control)
Number of subjects: 30
Study: 18688620

Group type: EXPERIMENTAL
Intervention: Portal vein infusion of 5-FU 500 mg/m² plus heparin for 24 hours for seven consecutive days plus mitomycin C 10 mg/m² on the first day
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 5-FU 500 mg/m² plus heparin for 24 hours for seven consecutive days plus mitomycin C 10 mg/m² on the first day
Number of subjects: 753

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 753
Study: 16174273

Group type: EXPERIMENTAL
Intervention: Vector system
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional ultrasonic scaler
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 46
Study: 14687818

Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 43

Group type: COMPARATOR
Intervention: N-Butyl-2-Cyanoacrylate (cyanoacrylate) glue injection
Number of subjects: 43
Study: 10732933

Group type: EXPERIMENTAL
Intervention: Let Me Decide advance directive program
Number of subjects: 1292
Study: 8819502

Group type: EXPERIMENTAL
Intervention: 2 mg/kg cocaine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1544117

Group type: EXPERIMENTAL
Intervention: Lumpectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lumpectomy followed by radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple operations
Number of subjects: 0
Study: 3899951

Group type: EXPERIMENTAL
Intervention: Oral verapamil 40 mg three times daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no antiarrhythmic agents)
Number of subjects: 100
Study: 31907186

Group type: EXPERIMENTAL
Intervention: Artesunate-Amodiaquine (200 mg AS/540 mg AQ) plus Methylene Blue (325 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Artesunate-Amodiaquine plus Methylene Blue
Number of subjects: 15

Group type: COMPARATOR
Intervention: Artesunate-Amodiaquine
Number of subjects: 15
Study: 29458933

Group type: EXPERIMENTAL
Intervention: Whole body cryotherapy (10 sessions over 8 days, in addition to usual care)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no change in everyday activities)
Number of subjects: 24
Study: 26713665

Group type: EXPERIMENTAL
Intervention: 4 weeks of preoperative progressive resistance training (PRT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 4 weeks of postoperative PRT only (control group)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 59
Study: 24668008

Group type: EXPERIMENTAL
Intervention: Transplanted kidneys
Number of subjects: 12

Group type: COMPARATOR
Intervention: Transplanted kidneys with normal function
Number of subjects: 12
Study: 22206795

Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg under fed conditions
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg under fasted conditions
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib 800 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib (various doses in Study A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib (all doses)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vandetanib (all studies)
Number of subjects: 43
Study: 20124784

Group type: EXPERIMENTAL
Intervention: Botox
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Prosigne
Number of subjects: 57
Study: 17196712

Group type: EXPERIMENTAL
Intervention: Galantamine (16-24 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16225930

Group type: EXPERIMENTAL
Intervention: 100% motor threshold (MT) rTMS
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 80% motor threshold (MT) rTMS
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 54
Study: 12364632

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1 mg/kg CDP870 (n = 8)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5 mg/kg CDP870 (n = 8)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20 mg/kg CDP870 (n = 8)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined treatment effect of CDP870 (0, 1, 5, 20 mg/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Open-label infusion of 5 or 20 mg/kg CDP870 (n = 32)
Number of subjects: 36
Study: 10856808

Group type: EXPERIMENTAL
Intervention: Class II copy-milled ceramic inlays
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Laboratory stage for Class II copy-milled ceramic inlays
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cavity modification technique (composite basing/conventional)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Clinical operator (seven dentists)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Size of the restoration (large/medium)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall working time for Class II copy-milled ceramic inlays
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Dentists' efficiency over time
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Laboratory time for inlay production
Number of subjects: 101
Study: 9327688

Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.46 ± 1.78; n = 94)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.71 ± 2.42; n = 295)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.53 ± 2.53; n = 184)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Injections before 90 minutes (mean 2.76 ± 2.03; n = 204)
Number of subjects: 389
Study: 8452276

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg bolus followed by infusion of 1 micrograms.kg‐1 x min‐1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg/kg bolus followed by infusion of 2 micrograms.kg‐1 x min‐1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Midazolam 0.4 mg/kg bolus followed by infusion of 4 micrograms.kg‐1 x min‐1
Number of subjects: 50

Group type: COMPARATOR
Intervention: No midazolam (Control)
Number of subjects: 50
Study: 3725003

Group type: EXPERIMENTAL
Intervention: Amitriptyline, 50 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29975270

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Percutaneous needle fasciotomy (PNF)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Both CCH and PNF
Number of subjects: 156
Study: 27710821

Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 382

Group type: COMPARATOR
Intervention: voglibose
Number of subjects: 382
Study: 24495514

Group type: EXPERIMENTAL
Intervention: Stop Delirium! intervention delivered over 16 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study: 23409601

Group type: EXPERIMENTAL
Intervention: Combination training group (1 x 9 reps with 3-kg medicine ball, followed by 3 x 14 reps with water polo ball)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Medicine-ball training group (3 x 6 reps with 3-kg medicine ball)
Number of subjects: 30
Study: 20634482

Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT) with cisplatin (100 mg/m² every 3 weeks for three cycles) plus radiotherapy
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT) with cisplatin plus radiotherapy
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Concurrent-adjuvant chemotherapy (CRT)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 348